This ISA application proposes to provide the applicant with release from teaching and administration responsibilities. The candidate's career goal is to become a leading researcher in the area of oxidative stress and heart diseases. In this application, the applicant plans to evaluate a protective mechanism against cardiac injury associated with reactive oxygen species (ROS) generating therapeutic agents. Many studies suggest that ROS are produced in vivo by a wide variety of agents and disease conditions, but the contribution to these ROS to development of cardiac injury is unclear. The hypothesis to be tested is that ROS generated in the mitochondria by therapeutic agents contribute to the cardiotoxicity of the therapeutic agents, and antioxidant enzymes modulate ROS-induced cardiomyopathy. To test this hypothesis, the expression of mitochondrial superoxide dismutase (MnSOD) and glutathione peroxidase (GPX) in heart tissue will be elevated by transgenic manipulations. The effect of ROS generating therapeutic agents on the heart tissue will be examined in transgenic mice expressing a range of MnSOD and/or GPX activity under experimental therapeutic conditions. The results obtained from this study should clearly demonstrate if increased mitochondrial antioxidant enzymes lead to protection of ROS mediated cardiomyopathy. The applicant is currently not only fully responsible for two courses but will also participate in a number of team-taught courses offered by the Graduate Center for Toxicology (GCT). In addition, the applicant serves on the committees of 17 graduate students, is a member of three administrative committees, and chairs the department's curriculum committee. With an ISA award, the applicant's teaching responsibility will be limited to one team-taught course in the subject of the research specialty. The applicant will also be relieved of 75% of her administrative duties. The redistribution of her effort will allow the applicant to concentrate on the research, including learning additional methodologies in cardiovascular research. As her most recent research has been focused on the molecular biology of antioxidant enzymes, the applicant has scheduled research at laboratories specializing in various aspects of cardiovascular research both at the University of Kentucky and elsewhere. The GCT will provide the applicant with research leave so that she can spend time at other institutions. Furthermore, the GCT will provide her with a post-doctoral associate position throughout the entire period of the award.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Scientist Development Award - Research (K02)
Project #
5K02HL003544-04
Application #
6043671
Study Section
Special Emphasis Panel (ZHL1-CSR-Y (M1))
Project Start
1996-08-01
Project End
2001-07-31
Budget Start
1999-08-01
Budget End
2000-07-31
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Kentucky
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
832127323
City
Lexington
State
KY
Country
United States
Zip Code
40506
Dhar, Sanjit K; Lynn, Bert C; Daosukho, Chotiros et al. (2004) Identification of nucleophosmin as an NF-kappaB co-activator for the induction of the human SOD2 gene. J Biol Chem 279:28209-19
Xu, Yong; Porntadavity, Sureerut; St Clair, Daret K (2002) Transcriptional regulation of the human manganese superoxide dismutase gene: the role of specificity protein 1 (Sp1) and activating protein-2 (AP-2). Biochem J 362:401-12
St Clair, Daret K; Porntadavity, Sureerut; Xu, Yong et al. (2002) Transcription regulation of human manganese superoxide dismutase gene. Methods Enzymol 349:306-12
Daosukho, Chotiros; Kiningham, Kelley; Kasarskis, Edward J et al. (2002) Tamoxifen enhancement of TNF-alpha induced MnSOD expression: modulation of NF-kappaB dimerization. Oncogene 21:3603-10
Yen, H C; Oberley, T D; Gairola, C G et al. (1999) Manganese superoxide dismutase protects mitochondrial complex I against adriamycin-induced cardiomyopathy in transgenic mice. Arch Biochem Biophys 362:59-66
Xu, Y; Krishnan, A; Wan, X S et al. (1999) Mutations in the promoter reveal a cause for the reduced expression of the human manganese superoxide dismutase gene in cancer cells. Oncogene 18:93-102
Kiningham, K K; Oberley, T D; Lin, S et al. (1999) Overexpression of manganese superoxide dismutase protects against mitochondrial-initiated poly(ADP-ribose) polymerase-mediated cell death. FASEB J 13:1601-10
Yeh, C C; Wan, X S; St Clair, D K (1998) Transcriptional regulation of the 5' proximal promoter of the human manganese superoxide dismutase gene. DNA Cell Biol 17:921-30
Majima, H J; Oberley, T D; Furukawa, K et al. (1998) Prevention of mitochondrial injury by manganese superoxide dismutase reveals a primary mechanism for alkaline-induced cell death. J Biol Chem 273:8217-24
Tomblyn, M; Kasarskis, E J; Xu, Y et al. (1998) Distribution of MnSOD polymorphisms in sporadic ALS patients. J Mol Neurosci 10:65-6